EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Histone lactylation as a driver of metabolic reprogramming and immune evasion

Qiaoting Cai, Wei Deng, Yutian Zou iD, Zhe-Sheng Chen iD, Hailin Tang

Medical Review · 13.06.2025 · 5 (3) · 256-259

DOI: 10.1515/mr-2024-0091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Review, online erschienen am 17.12.2024. Verfasst von Qiaoting Cai und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guan…. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lactate is the end product of glycolysis, and extensive research has shown that lactate participates in various pathophysiological processes. Along with associated hydrogen ions, lactate typically functions as an immunosuppressive negative factor and plays a crucial role in tumor metabolic reprogramming. The recently discovered lactylation is a novel epigenetic modification that, similar to other epigenetic modifications, modifies histones to alter chromatin spatial configuration, thereby affecting DNA accessibility and regulating gene expression. More importantly, the degree of lactylation is closely related to local lactate concentrations, establishing a link between epigenetics and metabolic reprogramming. During cellular metabolism, lactate accumulation promotes histone lysine lactylation in cancer cells and immune cells such as macrophages and T cells, playing an essential role in tumor immune evasion and resistance to immunotherapy. This paper details the role of lactylation modifications in cancer immune evasion and resistance to immunotherapy, providing novel therapeutic directions and targets for cancer treatment.

Schlagwörter

Stichwörter der Autor:innen

cancerhistone lactylationimmune escapeimmunotherapy resistance

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
  • College of Pharmacy and Health Sciences, St. John's University, Queens, NY, USA.

ORCID-Profile: Yutian Zou, Zhe-Sheng Chen

Zitieren

APA

Cai, Q., Deng, W., Zou, Y., Chen, Z. S., & Tang, H. (2025). Histone lactylation as a driver of metabolic reprogramming and immune evasion. Medical Review, 5(3), 256-259. https://doi.org/10.1515/mr-2024-0091

Vancouver

Cai Q, Deng W, Zou Y, Chen ZS, Tang H. Histone lactylation as a driver of metabolic reprogramming and immune evasion. Medical Review. 2025;5(3):256-259. doi:10.1515/mr-2024-0091

BibTeX
@article{Cai2025,
  author = {Cai, Qiaoting and Deng, Wei and Zou, Yutian and Chen, Zhe-Sheng and Tang, Hailin},
  title = {Histone lactylation as a driver of metabolic reprogramming and immune evasion},
  journal = {Medical Review},
  year = {2025},
  volume = {5},
  number = {3},
  pages = {256--259},
  doi = {10.1515/mr-2024-0091}
}
Kostenlos starten →